A detailed history of Fagan Associates, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fagan Associates, Inc. holds 2,495 shares of MRK stock, worth $261,550. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,495
Previous 2,495 -0.0%
Holding current value
$261,550
Previous $329,000 6.38%
% of portfolio
0.06%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$113.24 - $131.95 $11,324 - $13,194
100 Added 4.18%
2,495 $329,000
Q4 2023

Feb 07, 2024

SELL
$100.18 - $109.02 $10,018 - $10,902
-100 Reduced 4.01%
2,395 $261,000
Q3 2023

Oct 31, 2023

BUY
$102.95 - $114.33 $7,721 - $8,574
75 Added 3.1%
2,495 $256,000
Q2 2023

Aug 08, 2023

BUY
$108.61 - $118.38 $7,385 - $8,049
68 Added 2.89%
2,420 $279,000
Q2 2022

Aug 03, 2022

BUY
$83.49 - $94.64 $196,368 - $222,593
2,352 New
2,352 $214,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $266B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fagan Associates, Inc. Portfolio

Follow Fagan Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fagan Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fagan Associates, Inc. with notifications on news.